The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma


Heider, M., Eichner, R., Stroh, J., Morath, V., Kuisl, A., Zecha, J., Lawatscheck, J., Baek, K., Garz, A. K., Rudelius, M., Deuschle, F. C., Keller, U., Lemeer, S., Verbeek, M., Gotze, K. S., Skerra, A., Weber, W. A., Buchner, J., Schulman, B. A., Kuster, B., Fernandez-Saiz, V., Bassermann, F. (2021). Mol Cell 81, 1170-1186.e10.

DOI:10.1016/j.molcel.2020.12.046(link is external)